![Tina Albertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tina Albertson
Chief Tech/Sci/R&D Officer at
CARIBOU BIOSCIENCES, INC.
Net worth: 161 714 $ as of 31/05/2026
Profile
Tina Albertson currently works at Caribou Biosciences, Inc., as Chief Medical Officer from 2024.
Dr. Albertson also formerly worked at Seagen, Inc., as Medical Director from 2010 to 2015, Juno Therapeutics, Inc., as Vice President-Global Drug Development from 2015 to 2020, and Lyell Immunopharma, Inc., as Chief Medical Officer & Head-Development from 2020 to 2023.
Dr. Albertson received her doctorate degree from Stanford University, doctorate degree from the University of Washington, and undergraduate degree from the University of Oregon.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/02/2026 | 68,523 ( 0.07% ) | 161 714 $ | 31/05/2026 |
Tina Albertson active positions
| Companies | Position | Start |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 12/08/2024 |
Former positions of Tina Albertson
| Companies | Position | End |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/11/2023 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/04/2020 |
| SEAGEN INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Training of Tina Albertson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
- Stock Market
- Insiders
- Tina Albertson
